Page 7 - Read Online
P. 7

Topic: State of the Art in the Management of Oral Squamous Cell Carcinoma



            Current role in facial allograft

            transplantation: what have we learned?




            Pedro Infante-Cossio , Fernando Barrera-Pulido , Tomas Gomez-Cia , Domingo
                                                                   2
                                                                                          2
                                    1
            Sicilia-Castro , Alberto Garcia-Perla-Garcia , Purificacion Gacto-Sanchez , Jose-
                                                                                               2
                                                             1
                            2
            Maria Hernandez-Guisado , Araceli Lagares-Borrego , Rocio Narros-Gimenez ,
                                                                         2
                                                                                                      2
                                          1
            Juan-David Gonzalez-Padilla      1
            1 Department of Oral and Maxillofacial Surgery, Virgen del Rocio University Hospital, 41013 Seville, Spain.
            2 Department of Plastic and Reconstructive Surgery, Virgen del Rocio University Hospital, 41013 Seville, Spain.
            Address for correspondence: Dr. Pedro Infante-Cossio, Department of Oral and Maxillofacial Surgery, Virgen del Rocio University
            Hospital, Av. Manuel Siurot, 41013 Seville, Spain. E-mail: pinfante@us.es
                            Dr. Pedro Infante-Cossio, M.D., D.D.S., Ph.D., received both his medical and dental degree from the University of
                            Seville, Spain. He obtained his PhD degree and received his Oral and Maxillofacial Surgery training at the Virgen del
                            Rocio University Hospital, Seville, Spain. From 1994 he has been consultant in Oral and Maxillofacial Surgery at the
                            Virgen del Rocio University Hospital, Seville, Spain. Currently, he is Full Professor in Oral and Maxillofacial Surgery
                            at the Faculty of Medicine and Dentistry in Seville, Spain.

                  ABSTRACT
                  Face transplant (FT) has evolved enormously in the last 10 years since the successful completion
                  of the first facial transplant. This procedure has become a new reconstructive option for complex
                  facial deformities to restore the anatomy of patients with severely disfigured faces. The authors
                  review the literature and discuss the main surgical, immunological, and ethical aspects as
                  well  as  the  results described in  patients  undergoing  FT. To date  there  have  been more  than
                  thirty FT worldwide. The main indication was post-traumatic deformity. In all cases a standard
                  immunosuppression was performed with three drugs, although acute rejection episodes were
                  observed, that could be controlled with conventional immunosuppressive regimen. Overall,
                  functional and aesthetic results have been excellent at short-term and high satisfaction rate
                  exceeded initial expectations, although long-term data are still scarce. Major complications were
                  opportunistic infections. Five deaths that occurred have reopened the ethical debate about the
                  potential complications and concerns of providing informed consent to recipients. Continuous
                  progresses in microsurgical techniques and preoperative planning have promoted the evolution
                  from partial to full FT.  All these are on the basis of accurate and careful selection of well-
                  motivated candidates. The next challenge will be getting new immunosuppressive treatment
                  strategies. Although clinical experience has demonstrated the FT viability, it is still considered
                  an experimental procedure in which we have much to learn to define its true role in the current
                  reconstructive surgery and resolve major technical, medical and ethical problems involved.
                  Key words:
                  Face transplantation; composite tissue transplantation; facial allograft transplantation; facial
                  reconstruction; outcomes and complications of face transplantation


                                                              This is an open access article distributed under the terms of the Creative Commons
                                                              Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,
                                                              tweak and build upon the work non-commercially, as long as the author is credited
                           Access this article online         and the new creations are licensed under the identical terms.
                 Quick Response Code:                         For reprints contact: service@oaepublish.com
                                    Website:
                                    http://www.parjournal.net  How to cite this article: Infante-Cossio P, Barrera-Pulido F, Gomez-
                                                               Cia T, Sicilia-Castro D, Garcia-Perla-Garcia A, Gacto-Sanchez P,
                                                               Hernandez-Guisado JM, Lagares-Borrego A, Narros-Gimenez R,
                                                               Gonzalez-Padilla JD. Current role in facial allograft transplantation:
                                    DOI:                       what have we learned? Plast Aesthet Res 2016;3:211-8.
                                    10.20517/2347-9264.2016.11
                                                               Received: 28-03-2016; Accepted: 14-04-2016
            © 2016 Plastic and Aesthetic Research | Published by OAE Publishing Inc.                      211
   2   3   4   5   6   7   8   9   10   11   12